Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 22

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 22
---
-sale securities are held by two custodians who obtain investment prices from a third-party pricing provider that uses standard inputs (observable in the market) to models which vary by asset class.The following tables set forth by level within the fair value hierarchy our assets that are measured on a recurring basis and reported at fair value as of March 31, 2025 and December 31, 2024. Assets are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.Fair Value Measurements as ofMarch 31, 2025EstimatedFair ValueLevel 1Level 2Level 3Cash equivalents:Money market funds$29,758 $29,758 $— $— Total cash equivalents29,758 29,758 — — Investments:Commercial paper13,435 — 13,435 — Corporate debt securities75,583 — 75,583 — Certificates of deposit2,999 — 2,999 — Asset-backed securities158 — 158 — U.S. government securities267,963 267,963 — — Total investments360,138 267,963 92,175 — Total cash equivalents and investments$389,896 $297,721 $92,175 $— 

12

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

Fair Value Measurements as ofDecember 31, 2024EstimatedFair ValueLevel 1Level 2Level 3Cash equivalents:Money market funds$59,606 $59,606 $— $— Total cash equivalents59,606 59,606 — — Investments:Commercial paper19,831 — 19,831 — Corporate debt securities71,224 — 71,224 — Certificates of deposit7,694 — 7,694 — Asset-backed securities287 — 287 — U.S. government securities267,355 267,355 — — Total investments366,391 267,355 99,036 — Total cash equivalents and investments$425,997 $326,961 $99,036 $— There were no transfers between levels during the periods ended March 31, 2025 and December 31,